ДИСФУНКЦИЯ ПОЧЕК КАК ПРЕДИКТОР ПРОГРЕССИРОВАНИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
Аннотация
Представлен обзор подходов к ранней диагностике дисфункции почек у пациентов с артериальной гипертензией: актуальность проблемы, патогенетические механизмы, диагностика, новые направления в лечении и профилактике.
Литература
Shishkin AN. Disfunkcija jendotelija i mikroalbuminurija. Klinicheskoe znachenie i terapevticheskie podhody. In: Administracija Moskovskogo rajona Sankt-Peterburga. Peredovye medicinskie tehnologii prakticheskomu zdravoohraneniju. Materialy nauchno-prakticheskoj konferencii, posvjashhennoj 50-letiju gorodskoj klinicheskoj bolnicy № 20; 2008 Sept. 30; Sankt-Peterburg. Sankt-Peterburg: Izdatelstvo Sankt-Peterburgskogo gosudarstvennogo universiteta; 2008. p. 193-200. (Russian).
Arutjunov GP, Chernjavskaja TK. Problemy nefroprotekcii u pacientov s arterialnoj gipertoniej. Znachenie pokazatelja mikroalbuinurii dlja vracha obshhej praktiki. Kachestvo zhizni. Medicina. 2005;3:22-27. (Russian).
Barbuk OA. Cardiorenal syndrome: the main problems of diagnosis and treatment. Medicinskie novosti. 2018;3:60-65. edn: YUVZVU. (Russian).
Levey AS, Coresh J, Bolton K, Culleton B, Harvey KS, Ikizler TA, Johnson CA, Kausz A, Kimmel PL, Kusek J, Levin A, Minaker KL, Nelson R, Rennke H, Steffes M, Witten B. K/DOQI Clinical Practice Guidelines on Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-S266.
Batiushin MM. Chronic kidney disease: current state of the problem. Rational Pharmacotherapy in Cardiology. 2020;16(6):938-947. https://doi.org/10.20996/1819-6446-2020-11-06. https://www.elibrary.ru/whkbhv. (Russian).
Gu X, Fang X, Ji X, Tang Z, Wang C, Guan S, Wu X, Liu H, Zhang Z. Kidney dysfunction is associated with risk of cardiovascular events in middle-aged and elderly population with hypertension: A 5-year community-based cohort study in China. Clin Nephrol. 2020;93(3):130-139. https://doi.org/10.5414/CN109712.
Cha RH, Lee H, Lee JP, Kim YS, Kim SG. The influence of blood pressure patterns on renal outcomes in patients with chronic kidney disease: The long-term follow up result of the APrODiTe-2 study. Medicine (Baltimore). 2020;99(8):e19209. https://doi.org/10.1097/MD.0000000000019209.
Yu Z, Rebholz CM, Wong E, Chen Y, Matsushita K, Coresh J, Grams ME. Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2019;74(3):310-319. https://doi.org/10.1053/j.ajkd.2019.02.015.
Mallamaci F, Pisano A, Tripepi G. Physical activity in chronic kidney disease and the EXerCise introduction to Enhance trial. Nephrol Dial Transplant. 20201;35(Suppl 2):ii18-ii22. https://doi.org/10.1093/ndt/gfaa012.
Nikolaenko DO. Koncepcija hronicheskoj bolezni pochek – opyt primenenija v ambulatornoj praktike. In: Barkovskij EV, editor. Studencheskaja medicinskaja nauka v BGMU zdravoohraneniju Respubliki Belarus. Minsk: BGMU; 2014. p. 10. (Russian).
National Institute of Diabetes and Digestive and Kidney Diseases. Laboratory Evaluation of Kidney Disease [Internet]. Available from: https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/laboratory-evaluation.
Associacija nefrologov. Hronicheskaja bolezn pochek (HBP). Klinicheskie rekomendacii; 2021 [Internet]. Available from: https://rusnephrology.org/wp-content/uploads/2020/12/CKD_final.pdf (Russian).
Podzolkov VI, Bragina AE, Ishina TI, Bragina GI, Vasilyeva LV. Nephroprotective strategy in the treatment of hypertension as a modern general medical problem. Russian Journal of Cardiology. 2018;23(12):107-118. https://doi.org/10.15829/1560-4071-2018-12-107-118. https://www.elibrary.ru/yppbbr. (Russian).
Rein P, Boehnel C, Saely CH, Vonbank A, Beer S, Jankovic V, Breuss JF, Risch L, Drexelet H. Albuminuria is associated with angiographically determined coronary atherosclerosis both in patients with type 2 diabetes and in non-diabetic individuals. Circulation. 2010;122(Suppl 21):15491.
Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, Knoll GA, Muntner P, Pecoits-Filho R, Sarnak MJ, Sheldon W Tobe SW, Tomson С, Mann JF. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3):S1-S87. https://doi.org/10.1016/j.kint.2020.11.003.
Becker GJ, Wheeler DC, de Zeeuw D, Fujita T, Furth SL, Holdaas H, Mendis S, Oparil S, Perkovic V, Rodrigues CI, Sarnak MJ, Schernthaner G, Tomson CRV, Zoccali C, Oparil S. KDIGO 2012 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2012;2(5):337-414. https://doi.org/10.1038/kisup.2012.46.
Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-2116. https://doi.org/10.1056/NEJMoa1511939.
Shayman JA. Renal pathophysiology. Philadelphia: Lippincott; 1995. p. 170-174.
Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, He L, Su X. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017;32(3):475-487. https://doi.org/10.1093/ndt/gfw452.
White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009;24(8):2464-72. https://doi.org/10.1093/ndt/gfp114.
Zelle DM, Klaassen G, van Adrichem E, Bakker SJ, Corpeleijn E, Navis G. Physical inactivity: a risk factor and target for intervention in renal care. Nat Rev Nephrol. 2017;13(3):152-168. https://doi.org/10.1038/nrneph.2016.187.
Ajjarapu AS, Hinkle SN, Li M, Francis EC, Zhang C. Dietary Patterns and Renal Health Outcomes in the General Population: A Review Focusing on Prospective Studies. Nutrients. 2019;11(8):1877. https://doi.org/10.3390/nu11081877.
Malta D, Petersen KS, Johnson C, Trieu K, Rae S, Jefferson K, Santos JA, Wong MMY, Raj TS, Webster J, Campbell NRC, Arcand J. High sodium intake increases blood pressure and risk of kidney disease. From the Science of Salt: A regularly updated systematic review of salt and health outcomes (August 2016 to March 2017). J Clin Hypertens (Greenwich). 2018;20(12):1654-1665. https://doi.org/10.1111/jch.13408.
Haring B, Selvin E, Liang M, Coresh J, Grams ME, Petruski-Ivleva N, Steffen LM, Rebholz CM. Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study. J Ren Nutr. 2017;27(4):233-242. https://doi.org/10.1053/j.jrn.2016.11.004.
Jhee JH, Kee YK, Park JT, Chang TI, Kang EW, Yoo TH, Kang SW, Han SH. A Diet Rich in Vegetables and Fruit and Incident CKD: A Community-Based Prospective Cohort Study. Am J Kidney Dis. 2019;74(4):491-500. https://doi.org/10.1053/j.ajkd.2019.02.023.
van Westing AC, Küpers LK, Geleijnse JM. Diet and Kidney Function: a Literature Review. Curr Hypertens Rep. 2020;22(2):14. https://doi.org/10.1007/s11906-020-1020-1.
Asghari G, Yuzbashian E, Mirmiran P, Azizi F. The association between Dietary Approaches to Stop Hypertension and incidence of chronic kidney disease in adults: the Tehran Lipid and Glucose Study. Nephrol Dial Transplant. 2017;32(Suppl 2):ii224-ii230. https://doi.org/10.1093/ndt/gfw273.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-2219. https://doi.org/10.1093/eurheartj/eht151.
Chyzh KA, Tushina AK. The role of primary care physician in chronic kidney disease. Meditsinskie novosti. 2020;5:30-36. edn: MWLIXV. (Russian).
New indication registered for the medicine forciga® (dapagliflozin): chronic kidney disease. Diabetes mellitus. 2021;24(5):487. edn: USJZTU. (Russian).
Forsiga (Forxiga). Instrukcija po primeneniju [Internet]. Available from: https://www.vidal.ru/drugs/forxiga__43121 (Russian).
